Hence, considering the regulation of proliferation and cellular growth, the inhibition of PI3-K/Akt and mTOR signaling could be a promising therapeutic strategy in psoriasis such as the Vitamin D analog 1α, 25-dihydroxyvitamin D3-3-bromoacetate24, double kinase inhibitor22, as well as ScF. Here, KITLG is linked to psoriasis.